Gunnar Kratz

Gunnar Kratz

Auto-generated profile, based on publicly available information

Gunnar Kratz

Department of Biomedical and Clinical Sciences, Linköping University, Linköping, Sweden

Research Focus & Metrics

Academic Career Length

23Years (2004-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 September 2013 in Biochimica et Biophysica Acta (BBA) - Molecular Cell Research
Verified
Journal Article
Open access
JJJaganmohan Reddy Jangamreddy
Jaganmohan Reddy Jangamreddy
Saeid GhavamiSaeid Ghavami
Saeid Ghavami
JGJerzy Grabarek
Jerzy Grabarek
GKGunnar Kratz
Gunnar Kratz
EWEmilia Wiechec
Emilia Wiechec
Marek J. ŁosMarek J. Łos
Marek J. Łos
The molecular mechanism of Salinomycin's toxicity is not fully understood. Various studies reported that Ca(2+), cytochrome c, and caspase activation play a role in Salinomycin-induced cytotoxicity. Furthermore, Salinomycin may target Wnt/β-catenin signaling pathway to promote differentiation and thus elimination of cancer stem cells. In this study, we show a massive autophagic response to Salinomycin (substantially stronger than to commonly used autophagic inducer Rapamycin) in prostrate-, breast cancer cells, and to lesser degree in human normal dermal fibroblasts. Interestingly, autophagy induced by Salinomycin is a cell protective mechanism in all tested cancer cell lines. Furthermore, Salinomycin induces mitophagy, mitoptosis and increased mitochondrial membrane potential (∆Ψ) in a subpopulation of cells. Salinomycin strongly, and in time-dependent manner decreases cellular ATP level. Contrastingly, human normal dermal fibroblasts treated with Salinomycin show some initial decrease in mitochondrial mass, however they are largely resistant to Salinomycin-triggered ATP-depletion. Our data provide new insight into the molecular mechanism of preferential toxicity of Salinomycin towards cancer cells, and suggest possible clinical application of Salinomycin in combination with autophagy inhibitors (i.e. clinically-used Chloroquine). Furthermore, we discuss preferential Salinomycins toxicity in the context of Warburg effect.

20 November 2009 in Materials
Verified
Journal Article
Open access
PDF file
CFCamilla Fredriksson
Camilla Fredriksson
MHMy Hedhammar
My Hedhammar
RFRicardo Feinstein
Ricardo Feinstein
KNKerstin Nordling
Kerstin Nordling
GKGunnar Kratz
Gunnar Kratz
ARAnna Rising
Anna Rising
Spider silk is an interesting biomaterial for medical applications. Recently, a method for production of recombinant spider silk protein (4RepCT) that forms macroscopic fibres in physiological solution was developed. Herein, 4RepCT and MersilkTM (control) fibres were implanted subcutaneously in rats for seven days, without any negative systemic or local reactions. The tissue response, characterised by infiltration of macrophages and multinucleated cells, was similar with both fibres, while only the 4RepCT-fibres supported ingrowth of fibroblasts and newly formed capillaries. This in vivo study indicates that 4RepCT-fibres are well tolerated and could be used for medical applications, e.g., tissue engineering.

1 May 2021 in Burns
Verified
Journal Article
Open access
ALAlexander P. Larsson
Alexander P. Larsson
KBKristina Briheim
Kristina Briheim
VHVictor Hanna
Victor Hanna
KGKarin Gustafsson
Karin Gustafsson
ASAnnika Starkenberg
Annika Starkenberg
JJJohan P.E. Junker
Johan P.E. Junker

12 June 2025 in Advanced Healthcare Materials
Verified
Journal Article
Open access
RSRozalin Shamasha
Rozalin Shamasha
SRSneha Kollenchery Ramanathan
Sneha Kollenchery Ramanathan
KOKristin Oskarsdotter
Kristin Oskarsdotter
FBFatemeh Rasti Boroojeni
Fatemeh Rasti Boroojeni
AZAleksandra Zielińska
Aleksandra Zielińska
JJJohan Junker
Johan Junker
Chronic wounds and severe skin injuries pose significant clinical challenges, as existing treatments like cultured epidermal autografts and tissue engineering strategies fail to regenerate functional dermal tissue effectively. These methods often result in scarring due to poor tissue integration, low cell density, and limited extracellular matrix (ECM) production. Conventional skin tissue engineering relies on time‐intensive cell expansion, producing constructs that lack the complexity of native dermal structures. Here, a bioprintable biphasic granular hydrogel bioink (µInk) based on cell‐laden porous gelatin microcarriers (PGMs) is presented, enabling fabrication of ultra‐high cell density constructs that promote ECM production for dermal regeneration in vitro and in vivo. Primary human dermal fibroblasts are cultured and expanded on PGMs in a bioreactor prior µInk formulation. The cell‐laden PGMs are cross‐linked via copper‐free click chemistry, creating a shear‐thinning granular bioink. The µInk is 3D bioprinted into structurally stable constructs with high cell viability. In vivo, the bioprinted constructs supported neovascularization, hydrogel remodeling, and tissue integration over 28 days. Cells maintained their tissue‐specific phenotype, proliferated, and produced dermal ECM post‐transplantation. The µInk offers a promising approach to generating high cell‐density constructs for scar‐free wound healing and for advancing complex tissue reconstruction.

29 August 2019 in PLOS ONE
Verified
Journal Article
Open access
PDF file
SLSusanna Lönnqvist
Susanna Lönnqvist
JJJohan P. E. Junker
Johan P. E. Junker
MSMaria Sedell
Maria Sedell
ENErika Nyman
Erika Nyman
GKGunnar Kratz
Gunnar Kratz
The treatment of burn wounds and hypopigmentation conditions often require autologous transplantation of keratinocytes and melanocytes. Tracking transplanted cells to ascertain their contribution to tissue recapitulation presents a challenge. This study demonstrates a methodology based on passive staining with carboxyfluorescein hydroxysuccinimidyl ester (CFSE) that enables localization of cells in tissue sections to investigate the fate of transplanted cells in wound re-epithelialisation. Viability and migration of CFSE-stained keratinocytes and melanocytes were investigated using viability staining and scratch assays, while proliferation of cells was measured using flow cytometry. In addition, CFSE-stained keratinocytes and melanocytes were transplanted to a human ex vivo wound model, either in suspension, or with the aid of macroporous gelatine microcarriers. Wounds were analysed seven, 14 and 21 days post transplantation using cryosectioning and fluorescence microscopy. Sections from wounds with transplanted co-cultured keratinocytes and melanocytes were stained for pancytokeratin to distinguish keratinocytes. CFSE-staining of keratinocytes and melanocytes did not affect the viability, migration or proliferation of the cells. Transplanted cells were tracked in ex vivo wounds for 21 days, illustrating that the staining had no effect on wound re-epithelialisation. In conclusion, this study presents a novel application of CFSE-staining for tacking transplanted primary human keratinocytes and melanocytes.

8 July 2004
Verified
Journal Article
Closed access
Fredrik RM HussFredrik RM Huss
Fredrik RM Huss
UEUlf Erlandsson
Ulf Erlandsson
VCVernon Cooray
Vernon Cooray
GKGunnar Kratz
Gunnar Kratz
FSFolke Sjöberg
Folke Sjöberg